Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,266 | 402 | 98.2% |
| Education | $186.30 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,705 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,244 | 56 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,104 | 31 | $0 (2024) |
| GENZYME CORPORATION | $1,019 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $798.18 | 31 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $766.86 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $577.18 | 23 | $0 (2024) |
| Electromed, Inc. | $482.11 | 20 | $0 (2024) |
| Genentech USA, Inc. | $394.42 | 17 | $0 (2024) |
| Mylan Specialty L.P. | $386.97 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,460 | 87 | AstraZeneca Pharmaceuticals LP ($467.17) |
| 2023 | $2,942 | 118 | AstraZeneca Pharmaceuticals LP ($342.97) |
| 2022 | $2,541 | 100 | GlaxoSmithKline, LLC. ($595.01) |
| 2021 | $2,510 | 100 | GlaxoSmithKline, LLC. ($568.80) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Pulmonology | ||||||
| 12/19/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $30.33 | General |
| Category: Medical Device | ||||||
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Neurology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $35.97 | General |
| Category: Narcoplepsy | ||||||
| 11/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $33.90 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Cardiovascular | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.50 | General |
| Category: Narcoplepsy | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $80.86 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: Immunology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 981 | 1,195 | $514,823 | $78,370 |
| 2022 | 11 | 967 | 1,174 | $519,024 | $79,897 |
| 2021 | 10 | 911 | 1,153 | $487,321 | $80,289 |
| 2020 | 9 | 826 | 1,049 | $447,983 | $66,088 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 242 | 364 | $200,200 | $35,207 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 232 | $87,000 | $15,093 | 17.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 138 | 140 | $52,220 | $6,595 | 12.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 138 | 140 | $47,740 | $6,239 | 13.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $43,868 | $5,655 | 12.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 143 | 146 | $50,808 | $4,567 | 9.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $13,440 | $2,107 | 15.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 46 | 53 | $10,441 | $1,432 | 13.7% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 21 | 22 | $6,556 | $1,028 | 15.7% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 20 | 30 | $2,550 | $448.20 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 196 | 309 | $169,950 | $30,909 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 245 | $91,875 | $17,082 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $61,814 | $7,982 | 12.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 134 | 134 | $49,982 | $6,464 | 12.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 131 | 131 | $44,671 | $6,006 | 13.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 140 | 140 | $48,720 | $4,502 | 9.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $18,480 | $2,820 | 15.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 54 | 61 | $12,017 | $1,585 | 13.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 18 | $13,770 | $1,150 | 8.3% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2022 | 18 | 20 | $5,960 | $1,063 | 17.8% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 18 | 21 | $1,785 | $333.32 | 18.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 289 | $158,950 | $30,316 | 19.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 173 | 304 | $114,000 | $20,897 | 18.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 122 | 122 | $45,506 | $6,033 | 13.3% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 121 | 121 | $41,261 | $5,551 | 13.5% |
About Anna Gorelik, P.A
Anna Gorelik, P.A is a Medical healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1407139801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Gorelik, P.A has received a total of $10,453 in payments from pharmaceutical and medical device companies, with $2,460 received in 2024. These payments were reported across 405 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,266).
As a Medicare-enrolled provider, Gorelik has provided services to 3,685 Medicare beneficiaries, totaling 4,571 services with total Medicare billing of $304,644. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Brooklyn, NY
- Active Since 09/21/2011
- Last Updated 11/03/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1407139801
Products in Payments
- DUPIXENT (Biological) $2,242
- NUCALA (Biological) $842.67
- TRELEGY ELLIPTA (Drug) $837.45
- SMARTVEST (Device) $482.11
- WAKIX (Drug) $440.20
- TEZSPIRE (Biological) $422.79
- BREZTRI (Drug) $407.91
- STIOLTO RESPIMAT (Drug) $395.36
- Xolair (Biological) $394.42
- Wakix (Drug) $326.66
- XOLAIR (Drug) $278.10
- XOLAIR (Biological) $276.35
- AIRSUPRA (Drug) $247.47
- Yupelri (Drug) $231.86
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $214.56
- OFEV (Drug) $200.48
- FASENRA (Biological) $200.47
- XYWAV (Drug) $197.22
- YUPELRI (Drug) $155.11
- NUZYRA (Drug) $144.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Brooklyn
Carl Clarke, Rpa-C, RPA-C
Medical — Payments: $115,985
Catherine Sekansky, Pa-C, PA-C
Medical — Payments: $20,836
Mr. Phillip Scotti, Pa-C, PA-C
Medical — Payments: $20,375
Vita Oklander, Pa-C, PA-C
Medical — Payments: $11,352
Mrs. Margret Levin, Pa-C, PA-C
Medical — Payments: $9,718
Ms. Verna Broughton, Pa, PA
Medical — Payments: $7,753